Formerly dba Parsortix Inc, ANGLE North America, Inc., - now the US facility of the UK owned parent firm - a medical technology company, offering prenatal diagnostics products. The company's product identifies chromosomal abnormalities in the first trimester of pregnancy offering the capacity for early diagnosis for chromosomal abnormalities associated with spina bifida, Down's, Turner, and Klinefelter syndromes. The company's technology, developed in laboratories in the United States and Europe, is also applicable to bone marrow transplant procedures used in cancer treatment. ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLEs proven. patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins. ANGLE has also recently launched a product for the research-use market and has an In-vitro Diagnostic Devices Directive CE Mark for the indicated clinical use. The FDA clearance process is currently underway for the clinical market in the US.
